✉news BusinessLabor first seen 11 d ago, last 10 d ago, peak #17
AstraZeneca signs $40 million AI drug discovery deal with insitro
Original: AstraZeneca strikes $40 million AI drug discovery deal with insitro
AstraZeneca has agreed a $40 million deal with AI drug discovery startup insitro to use machine learning in developing new medicines. The partnership marks another step by a major pharmaceutical company to bring artificial intelligence into early-stage drug research. Observers see it as part of a broader industry push to cut discovery timelines and costs.
Why now: A major pharma company committing significant money to AI-driven drug discovery fits the current wave of interest in AI applications in healthcare.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2362545